Mostrar el registro sencillo

dc.contributor.authorLópez Mejías, Raquel
dc.contributor.authorCastañeda, Santos
dc.contributor.authorGenre, Fernanda
dc.contributor.authorRemuzgo Martínez, Sara
dc.contributor.authorCarmona, F. David
dc.contributor.authorLlorca Díaz, Francisco Javier 
dc.contributor.authorBlanco Alonso, Ricardo 
dc.contributor.authorMartín, Javier
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2019-02-08T17:47:06Z
dc.date.available2019-02-08T17:47:06Z
dc.date.issued2018
dc.identifier.issn1568-9972
dc.identifier.issn1873-0183
dc.identifier.urihttp://hdl.handle.net/10902/15688
dc.description.abstractImmunoglobulin-A vasculitis (IgAV) is classically a childhood small-sized blood vessel vasculitis with predominant involvement of the skin. Gastrointestinal and joint manifestations are common in patients diagnosed with this condition. Nephritis, which is more severe in adults, constitutes the most feared complication of this vasculitis. The molecular bases underlying the origin of IgAV have not been completely elucidated. Nevertheless, several pieces of evidence support the claim that genes play a crucial role in the pathogenesis of this disease. The human leukocyte antigen (HLA) region is, until now, the main genetic factor associated with IgAV pathogenesis. Besides a strong association with HLA class II alleles, specifically HLA-DRB1 alleles, HLA class I alleles also seem to influence on the predisposition of this disease. Other gene polymorphisms located outside the HLA region, including those coding cytokines, chemokines, adhesion molecules as well as those related to T-cells, aberrant glycosylation of IgA1, nitric oxide production, neoangiogenesis, renin-angiotensin system and lipid, Pyrin and homocysteine metabolism, may be implicated not only in the predisposition to IgAV but also in its severity. An update of the current knowledge of the genetic component associated with the pathogenesis of IgAV is detailed in this review.es_ES
dc.description.sponsorshipAcknowledgements: RL-Mis supported by the Miguel Servet I programme of the Spanish Ministry of Economy and Competitiveness through the grant CP16/ 00033. FG is recipient of a Sara Borrell postdoctoral fellowship from the “Instituto Carlos III de Salud” at the Spanish Ministry of Health (Spain) (CD15/00095). SR-M is supported by funds from the RETICS Program (RIER) (RD16/0012/0009). FDC is supported by the Ramón y Cajal programme of the Spanish Ministry of Economy and Competitiveness through the grant RYC-2014-16458.es_ES
dc.format.extent15 p.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rights© 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND licensees_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceAutoimmun Rev. 2018 Mar;17(3):301-315es_ES
dc.subject.otherGeneticses_ES
dc.subject.otherHenoch-Schönlein Purpuraes_ES
dc.subject.otherImmunoglobulin-A Vasculitises_ES
dc.titleGenetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated reviewes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1016/j.autrev.2017.11.024es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1016/j.autrev.2017.11.024
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND licenseExcepto si se señala otra cosa, la licencia del ítem se describe como © 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license